Top News

• FDA Reinspection of Troubled Novo Nordisk Facility
• Induced Infringement Decision Analyzed
• Gilead/Merck Stop Trodelvy/Keytruda Study
• Lilly's Oral GLP-1 Outperforms Oral Semaglutide in Diabetes Trial
• AMA Delegates Call for Tighter FDA Oversight of Unapproved Peptides
• CGMP Violations Found in Zydus Record Review
• Senators Introduce Bill for Homeopathic Product Pathway
• CGMP Issues Cited at Hubei Gedian Humanwell